Who owns BOLT BIOTHERAPEUTICS INC?
- Ticker: BOLT
- CUSIP Number: 097702203
Tip: Access positions for across all investors
Analyze quarterly positions in Bolt Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bolt Biotherapeutics stock
Who bought or sold BOLT BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sofinnova Ventures | 138k | $556k | 0% | Mar 2026 |
|
| Pivotal bioVenture Partners Investment Advisor | 95k | $517k | 0% | Dec 2025 |
|
| Vivo Capital | 72k | $293k | 0% | Mar 2026 |
|
| Nan Fung Group Holdings | 58k | $319k | 0% | Dec 2025 |
|
| Renaissance Technologies | 55k | $301k | 92% | Dec 2025 |
|
| T3 Companies | 38k | $154k | 100% | Mar 2026 |
|
| Board of Trustees of The Leland Stanford Junior University | 36k | $145k | 0% | Mar 2026 |
|
| Pfizer | 31k | $137k | 0% | Mar 2026 |
|
| Lynx1 Capital Management | 31k | $124k | 100% | Mar 2026 |
|
| Geode Capital Management | 29k | $116k | 53% | Mar 2026 |
|
| Nano Cap New Millennium Growth Fund | 21k | $112k | 100% | Dec 2025 |
|
| Shay Capital | 15k | $60k | 100% | Mar 2026 |
|
| Vanguard Group | 10k | $56k | -70% | Dec 2025 |
|
| Citadel Advisors | 10k | $41k | 100% | Mar 2026 |
|
| BlackRock | 9.7k | $39k | 0% | Mar 2026 |
|
| Vanguard Capital Management | 7.1k | $29k | 100% | Mar 2026 |
|
| Morgan Stanley | 3.2k | $13k | 2% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 3.1k | $13k | 100% | Mar 2026 |
|
| UBS Group | 787.00 | $3.1k | 53% | Mar 2026 |
|
| Tower Research Capital | 723.00 | $4.0k | 179% | Dec 2025 |
|
| Vanguard Global Advisers | 24.00 | $97.000800 | 100% | Mar 2026 |
|
| SBI Securities | 10.00 | $40.000000 | 0% | Mar 2026 |
|
| Barclays | 6.00 | $33.000000 | 0% | Dec 2025 |
|
Who sold out of Bolt Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Susquehanna International | Sep 2025 | 17k | $89k |
| None | Dec 2025 | 15k | $84k |
| Jpmorgan Chase & Co | Sep 2025 | 42.00 | $222.999000 |